MedPath

Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Standard Lifestyle Intervention
Behavioral: Modified Lifestyle Intervention
Registration Number
NCT04073394
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, and weight loss maintenance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
215
Inclusion Criteria
  • Adults with obesity (BMI >30Kg/m2); these will be otherwise healthy individuals with no unstable psychiatric disease and uncontrolled life-threatening comorbidities (i.e. unstable angina).
  • Age: 18-65 years.
  • Gender: Men or women.
Exclusion Criteria
  • Weight change greater than 3% in the previous 3 months (weight stable).
  • History of bariatric surgery including lap band and bariatric endoscopy.
  • Significant untreated psychiatric dysfunction including binge eating disorders and bulimia.
  • Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM
  • A positive score on the AUDIT-C questionnaire as judged by an investigator.
  • Patient has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder study adherence

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Standard Lifestyle InterventionStandard Lifestyle InterventionParticipants in this group will be instructed to follow a standard low calorie diet, recommended to have 30 minutes of physical activity 3-5 days per week, and will be followed by a wellness couch weekly.
Modified Lifestyle InterventionModified Lifestyle InterventionParticipants in this group will have a tailored diet, exercise, and behavioral plan according to their obesity phenotype.
Primary Outcome Measures
NameTimeMethod
12-week total body weight loss12 weeks

Change in body weight during the 12 week study

Secondary Outcome Measures
NameTimeMethod
Gastric Emptying 2 Hours12 weeks

Change in gastric emptying percentage at 2 hours during the 12 week study using scintigraphy

Waist Circumference12 weeks

Change in waist circumference (cm)

Responder Rate12 weeks

Proportion of patients losing \> 3% of total body weight

Fat Loss12 weeks

Change in fat mass during the 12 week study using DEXA

Gastric Emptying12 weeks

Change in half gastric emptying time during the 12 week study using scintigraphy

Adherence12 weeks

Adherence and compliance with program defined by the number of contacts with the team

Calorie Intake12 weeks

Change in daily calorie intake

Anxiety Level12 weeks

Change is anxiety level during the 12 week study using the HADS-A scale

Emotional Eating12 weeks

Change is emotional eating level during the 12 week study using the TFEQ score

Calories to Fullness12 weeks

Change in calories consumed to fullness during the 12 week study using satiation test

Resting Metabolic Rate12 weeks

Change in resting energy expenditure during the 12 week study using an indirect calorimetry

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath